Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report) was the target of a large decrease in short interest in January. As of January 15th, there was short interest totalling 55,100 shares, a decrease of 9.7% from the December 31st total of 61,000 shares. Based on an average trading volume of 175,200 shares, the days-to-cover ratio […]
StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research report report published on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, Maxim Group upgraded Galmed Pharmaceuticals from a hold rating to a buy rating in a research note on Monday, July 24th. Check Out […]
Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated by Analysts at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.